What is the recommended treatment for tinea capitis in a child?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Tinea Capitis in Children

The recommended first-line treatment for tinea capitis in children is oral antifungal therapy, with the choice guided by the causative organism: terbinafine for Trichophyton species infections and griseofulvin for Microsporum species infections. 1

Diagnosis and Initial Assessment

  • Treatment can be initiated while awaiting confirmatory mycology if clinical signs are present:

    • Scale
    • Lymphadenopathy
    • Alopecia
    • Kerion (inflammatory mass) 2, 1
  • Obtain scalp samples via:

    • Scalpel scraping
    • Hair pluck
    • Brush or swab
    • Process all specimens for microscopy and culture to identify the causative organism 2, 1

Treatment Algorithm

First-line Treatment

  1. For Trichophyton species infections (e.g., T. tonsurans, T. violaceum, T. soudanense):

    • Terbinafine (oral) for 2-4 weeks 2, 1
    • Dosing by weight:
      • < 20 kg: 62.5 mg daily
      • 20-40 kg: 125 mg daily
      • 40 kg: 250 mg daily 2, 1

  2. For Microsporum species infections (e.g., M. canis, M. audouinii):

    • Griseofulvin (oral) for 6-8 weeks 2, 1, 3
    • Dosing by weight:
      • < 50 kg: 15-20 mg/kg/day (single or divided dose)
      • 50 kg: 1 g/day (single or divided dose) 2, 1, 3

  3. When causative organism is unknown:

    • Begin with griseofulvin as it has broader coverage and a long track record of safety in children 2, 4, 5

Second-line Treatment (for treatment failures)

  • Itraconazole: 5 mg/kg/day for 4 weeks (effective against both Trichophyton and Microsporum species) 2, 1

  • Fluconazole: Can be considered, especially in younger children who may benefit from the liquid formulation 6

Important Clinical Considerations

Treatment Duration and Follow-up

  • Continue treatment until mycological cure is achieved 1, 3
  • Clinical improvement is typically expected within 1-2 weeks 1
  • For Microsporum infections treated with griseofulvin, a full 6-8 weeks of treatment is necessary 2, 3
  • Recent evidence shows that griseofulvin remains effective for Microsporum species infections even in cases where terbinafine and itraconazole have failed 7

Adjunctive Therapy

  • Topical therapy alone is not effective for tinea capitis; oral therapy is required 2, 1
  • Sporicidal shampoos (e.g., selenium sulfide) can help remove scales and reduce spore viability, potentially decreasing spread 6

Prevention of Spread and Recurrence

  • Screen and treat all infected family members simultaneously 1
  • Avoid sharing personal items such as combs, brushes, and hats 1
  • Apply antifungal powders to prevent reinfection 1

Special Considerations

  • Safety profile: Griseofulvin has the longest track record of safety in children and is FDA-approved specifically for tinea capitis in pediatric patients 3, 4

  • Common side effects:

    • Griseofulvin: Gastrointestinal disturbances and rashes in <8% of patients 2
    • Terbinafine: Generally well-tolerated with occasional gastrointestinal and dermatological events 1
  • Treatment failures: Consider:

    • Lack of compliance
    • Suboptimal absorption
    • Relative insensitivity of the organism
    • Reinfection 2
  • For recalcitrant cases: If terbinafine or itraconazole fails in Microsporum infections, switching to griseofulvin often leads to successful outcomes 7

References

Guideline

Fungal Infections Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.